Market research
PRN.TO Profound Medical Corp
TO CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 289M
- P/E ratio
- Not available
- Analyst target
- 25.03
- Dividend yield
- Not available
- Beta
- 0.5
Profile
Company facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA74319B5027
- Market cap
- 289M
- P/E ratio
- Not available
- Analyst target
- 25.03
- Dividend yield
- Not available
- Beta
- 0.5
About
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PRN.TO discussion.
5 years, 5 months ago
Profound Medical Corp is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.
From a valuation standpoint, the stock is 94.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 53.3.
Profound Medical Corp's total revenue rose by 161.3% to $7M since the same quarter in the previous year.
Its net income has dropped by 319.7% to $-22M since the same quarter in the previous year.
Finally, its free cash flow grew by 9.1% to $-7M since the same quarter in the previous year.
Based on the above factors, Profound Medical Corp gets an overall score of 3/5.